Vira Shield 4This page contains information on Vira Shield 4 for veterinary use.
The information provided typically includes the following:
- Vira Shield 4 Indications
- Warnings and cautions for Vira Shield 4
- Direction and dosage information for Vira Shield 4
Vira Shield 4This treatment applies to the following species:
Bovine Rhinotracheitis-Virus Diarrhea Vaccine
For Use In Animals Only
Vira Shield 4 Indications
For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.
ADJUVANT: Xtend® SP.
Directions For Use
Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4-5 weeks. Vaccinate dairy cows at dry-off. Revaccinate annually or as recommended by your veterinarian.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2011 Novartis; Registered trademarks of Novartis AG
NAC No.: 11141120
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241
|Every effort has been made to ensure the accuracy of the Vira Shield 4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2016 North American Compendiums. Updated: 2016-06-30